Global Scans
·
Brain Technologies
·
Weekly Summary
[New] Leading Product Type: Non-invasive brain computers are projected to represent the leading product type in 2026, accounting for 58% of the revenue share, driven by safety, ease of use, and widespread adoption in healthcare, consumer, and research applications.
Persistence Market Research
[New] A machine-learning analysis of brain waves recorded during sleep may help identify people at high risk of developing dementia.
News-Medical
[New] Neuralink will begin high-volume production of its Brain-Computer Interface in 2026 - with nearly fully automated surgery.
>>>> >>>
[New] Brain emulation, Andregg suggests, could eventually allow humans to flourish in a world with superintelligence.
The Guardian
[New] Without robust, enduring implants, the true potential of brain-computer interfaces 2026 advancements remains largely untapped, confined to short-term research rather than permanent solutions.
Emre Arslan
[New] Advances in brain-computer interfaces and neurodata collection could enable unprecedented forms of cognitive influence.
Military.com
[New] Beijing last year classified brain-computer interfaces as a strategic sector and issued a roadmap calling for two or three globally competitive companies by 2030.
TESLARATI
[New] Brain-Computer Interfaces and deep brain stimulators will be top neurotech implants in 2026.
Pharmadocx Consultants
Economic models estimate global annual loss due to brain health degradation at $16 trillion by 2030, whereas investments in brain capital promise $26 trillion in GDP gains.
PubMed Central (PMC)
From 2025 to 2032, neuroinformatics and brain network analysis are projected to grow at a CAGR of approximately 8.2%, driven by the rising need for comprehensive neural connectivity mapping, especially in psychiatric and neurodegenerative disorders.
Persistence Market Research
China could see brain-computer interface (BCI) technology move into practical public use within three to five years as products mature, a leading BCI expert said, as Beijing races to catch up with U.S. startups including Elon Musk's Neuralink.
The Japan Times
Elon Musk has said that his brain implant startup Neuralink will begin 'high-volume production' of brain-computer interface devices and move to an entirely automated procedure in 2026.
Mint
Neuralink, the company owned by American entrepreneur Elon Musk, plans to launch mass production of brain implants and transition to a fully automated surgical procedure for their implantation in 2026.
>>>>>> >>>>>>>>>>>. <
Hearing loss is more common as we age and previous research has found it may increase the risk of memory and thinking problems, including dementia, but less is known about how treating hearing loss with hearing aids may impact brain health.
ScienceDaily
Fastest-Growing Therapeutic Area:Neurology is anticipated to grow at the fastest CAGR from 2026 to 2035, supported by expanding applications in brain imaging and neurodegenerative disease diagnostics.
Yahoo Finance
Women's brain health is estimated as a $250 billion opportunity, representing 26% of the famous $1 trillion gap.
Pharmaphorum
For instance, SpaceX's rumored $1.5 trillion IPO and Neuralink's advancements in brain-computer interface technology could gain traction in a regulatory environment increasingly influenced by Musk's lobbying efforts.
Ainvest
As for the ethics that confront brain-implanted or manipulating devices, China plans to strengthen informed-consent requirements, broaden ethics review beyond medicine, and move toward unified technical standards for clinical evaluation.
TechCrunch
See which emerging technologies will shape enterprise strategy and investment in 2026; from post-quantum cryptography to neuromorphic computing and next-generation infrastructure.
Juniper Research Ltd
Last updated: 29 March 2026
Hi,
Would you like a quick online demo of our service from an experienced member of our team?